Aliskiren Trial in Type 2 Diabetes Using Cardiorenal Endpoints - ALTITUDE

Description:

The goal of the trial was to evaluate treatment with the direct renin inhibitor aliskiren compared with placebo among patients with type 2 diabetes, renal dysfunction, cardiovascular disease, or both.